Surgery Partners Stock (NASDAQ:SGRY)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$15.99

52W Range

$11.41 - $24.10

50D Avg

$14.82

200D Avg

$15.71

Market Cap

$2.10B

Avg Vol (3M)

$1.45M

Beta

1.89

Div Yield

-

SGRY Company Profile


Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

16,000

IPO Date

Sep 30, 2015

Website

SGRY Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Private Insurance$1.69B$1.63B$1.42B
Self-Pay Revenue$87.60M$82.30M$68.10M
Other Services$82.40M$59.90M$42.90M
Government Revenue$1.38B$1.26B$1.13B
Healthcare Organization, Patient Service$3.23B$3.05B$2.70B
Other Patient Service Revenue Sources$71.20M$81.10M$85.60M

Fiscal year ends in Dec 25 | Currency in USD

SGRY Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.31B$3.11B$2.74B
Operating Income$389.50M$348.80M$328.00M
Net Income$-77.90M$-168.10M$-11.90M
EBITDA$-192.50M$501.40M$446.10M
Basic EPS$-0.61$-1.33$-0.09
Diluted EPS$-0.61$-1.33$-0.09

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Mar 03, 26 | 8:30 AM
Q3 25Nov 10, 25 | 8:30 AM

Peer Comparison


TickerCompany
IDYAIDEAYA Biosciences, Inc.
HTFLHeartflow, Inc. Common Stock
ARDTArdent Health Inc.
BKDBrookdale Senior Living Inc.
ATECAlphatec Holdings, Inc.
CDTXCidara Therapeutics, Inc.
LIVNLivaNova PLC
ZLABZai Lab Limited
LEGNLegend Biotech Corporation
SRRKScholar Rock Holding Corporation